Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Alkermes Plc. (ALKS)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Alkermes Plc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1520262.
Total stock buying since 2015: $1,582,948.
Total stock sales since 2015: $221,939,344.
Total stock option exercises since 2015: $86,692,070.
Table 3. Detailed insider trading at Alkermes Plc. (ALKS) , Part 2
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2022-06-14 | Anstice David W (Director) | Option Ex | 7,585 | .00 | 0 |
2022-06-09 | Alva Emily Peterson (Director) | Option Ex | 4,328 | .00 | 0 |
2022-06-05 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 3,500 | .00 | 0 |
2022-05-17 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Sale | 50,000 | 29.15 | 1,457,500 |
2022-05-17 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 50,000 | 16.55 | 827,500 |
2022-05-10 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Sale | 25,000 | 27.21 | 680,375 |
2022-05-10 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 25,000 | 16.55 | 413,750 |
2022-05-06 | Pops Richard F (Director and CEO, Alkermes plc) | Sale | 93,747 | 27.86 | 2,611,322 |
2022-05-06 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 120,847 | 16.55 | 2,000,017 |
2022-05-05 | Pops Richard F (Director and CEO, Alkermes plc) | Sale | 253,510 | 28.27 | 7,167,234 |
2022-05-05 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 329,153 | 16.55 | 5,447,482 |
2022-05-03 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Sale | 25,000 | 28.62 | 715,425 |
2022-05-03 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 25,000 | 16.55 | 413,750 |
2022-05-02 | Cooke Shane (Director) | Sale | 10,000 | 29.23 | 292,330 |
2022-05-02 | Cooke Shane (Director) | Option Ex | 10,000 | 16.55 | 165,500 |
2022-04-25 | Cooke Shane (Director) | Sale | 10,000 | 27.89 | 278,850 |
2022-04-25 | Cooke Shane (Director) | Option Ex | 10,000 | 16.55 | 165,500 |
2022-04-20 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Sale | 49,999 | 29.61 | 1,480,320 |
2022-04-20 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 49,999 | 16.55 | 827,483 |
2022-04-18 | Cooke Shane (Director) | Sale | 10,000 | 28.88 | 288,750 |
2022-04-18 | Cooke Shane (Director) | Option Ex | 10,000 | 16.55 | 165,500 |
2022-04-11 | Cooke Shane (Director) | Sale | 10,000 | 29.26 | 292,600 |
2022-04-11 | Cooke Shane (Director) | Option Ex | 10,000 | 16.55 | 165,500 |
2022-04-04 | Cooke Shane (Director) | Sale | 10,000 | 28.18 | 281,850 |
2022-04-04 | Cooke Shane (Director) | Option Ex | 10,000 | 16.55 | 165,500 |
2022-03-04 | Snyderman Nancy Lynn Md (Director) | Buy | 427 | 23.43 | 10,004 |
2022-02-23 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 11,983 | 24.76 | 296,651 |
2022-02-22 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 9,503 | .00 | 0 |
2022-02-22 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 6,969 | .00 | 0 |
2022-02-22 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 12,037 | .00 | 0 |
2022-02-22 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 7,286 | .00 | 0 |
2022-02-22 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 6,969 | .00 | 0 |
2022-02-22 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 5,543 | .00 | 0 |
2022-02-21 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 4,800 | .00 | 0 |
2022-02-21 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 6,875 | .00 | 0 |
2022-02-21 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 6,875 | .00 | 0 |
2022-02-21 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 4,800 | .00 | 0 |
2022-02-21 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 5,825 | .00 | 0 |
2022-02-21 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 32,400 | .00 | 0 |
2022-02-20 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 4,589 | .00 | 0 |
2022-02-20 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 3,824 | .00 | 0 |
2022-02-20 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 10,096 | .00 | 0 |
2022-02-20 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 7,036 | .00 | 0 |
2022-02-20 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 4,589 | .00 | 0 |
2022-02-20 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 5,354 | .00 | 0 |
2022-02-18 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 2,306 | 25.17 | 58,042 |
2022-02-16 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 2,375 | .00 | 0 |
2022-02-16 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 3,375 | .00 | 0 |
2022-02-16 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 3,375 | .00 | 0 |
2022-02-16 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 2,375 | .00 | 0 |
2022-02-16 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 3,375 | .00 | 0 |
2022-02-16 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 18,125 | .00 | 0 |
2021-12-02 | Gaynor Richard (Director) | Option Ex | 5,578 | .00 | 0 |
2021-12-02 | Snyderman Nancy Lynn Md (Director) | Option Ex | 5,578 | .00 | 0 |
2021-12-02 | Cooke Shane (Director) | Option Ex | 5,578 | .00 | 0 |
2021-12-02 | Wilson Frank Anders (Director) | Option Ex | 5,578 | .00 | 0 |
2021-12-02 | Wysenski Nancy (Director) | Option Ex | 5,578 | .00 | 0 |
2021-12-02 | Dixon Wendy L (Director) | Option Ex | 5,578 | .00 | 0 |
2021-12-02 | Anstice David W (Director) | Option Ex | 5,578 | .00 | 0 |
2021-08-23 | Alva Emily Peterson (Director) | Buy | 1,650 | 30.21 | 49,854 |
2021-08-19 | Brown Iain Michael (SVP, Chief Financial Officer) | Sale | 40,000 | 29.99 | 1,199,600 |
2021-08-19 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 40,000 | 16.55 | 662,000 |
2021-08-02 | Mckeon Brian P (Director) | Buy | 10,000 | 26.43 | 264,270 |
2021-07-29 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Sale | 14,000 | 26.00 | 364,000 |
2021-07-29 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 14,000 | 16.55 | 231,700 |
2021-06-10 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Sale | 13,500 | 25.00 | 337,500 |
2021-06-10 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 13,500 | 16.55 | 223,425 |
2021-06-10 | Dixon Wendy L (Director) | Sale | 25,000 | 25.00 | 625,000 |
2021-06-10 | Dixon Wendy L (Director) | Option Ex | 25,000 | 18.21 | 455,250 |
2021-06-09 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 882 | 24.60 | 21,697 |
2021-06-07 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 1,250 | .00 | 0 |
2021-06-07 | Anstice David W (Director) | Sale | 5,000 | 24.00 | 120,000 |
2021-06-07 | Anstice David W (Director) | Option Ex | 5,000 | 14.60 | 73,000 |
2021-06-05 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 3,500 | .00 | 0 |
2021-05-20 | Gaynor Richard (Director) | Option Ex | 6,104 | .00 | 0 |
2021-05-20 | Snyderman Nancy Lynn Md (Director) | Option Ex | 6,104 | .00 | 0 |
2021-05-20 | Wysenski Nancy (Director) | Option Ex | 6,104 | .00 | 0 |
2021-05-20 | Mitchell Paul J (Director) | Option Ex | 6,104 | .00 | 0 |
2021-05-18 | Pops Richard F (Director and CEO, Alkermes plc) | Sale | 150,000 | 21.90 | 3,285,450 |
2021-05-18 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 150,000 | 18.11 | 2,715,750 |
2021-05-17 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Sale | 50,000 | 22.09 | 1,104,650 |
2021-05-17 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 50,000 | 18.11 | 905,250 |
2021-05-14 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Sale | 2,250 | 22.23 | 50,017 |
2021-05-14 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 2,250 | 18.11 | 40,736 |
2021-05-07 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Sale | 19,477 | 22.10 | 430,519 |
2021-05-07 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 19,477 | 18.11 | 352,631 |
2021-05-06 | Pops Richard F (Director and CEO, Alkermes plc) | Sale | 100,000 | 21.79 | 2,179,400 |
2021-05-06 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 100,000 | 18.11 | 1,810,500 |
2021-04-19 | Brown Iain Michael (SVP, Chief Financial Officer) | Sale | 34,792 | 20.00 | 695,770 |
2021-04-19 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 34,792 | 18.11 | 629,909 |
2021-04-19 | Dixon Wendy L (Director) | Sale | 25,000 | 20.00 | 500,125 |
2021-04-19 | Dixon Wendy L (Director) | Option Ex | 25,000 | 14.60 | 365,000 |
2021-04-16 | Brown Iain Michael (SVP, Chief Financial Officer) | Sale | 208 | 19.99 | 4,157 |
2021-04-16 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 208 | 18.11 | 3,765 |
2021-04-15 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 28,920 | 19.72 | 570,302 |
2021-02-21 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 4,800 | .00 | 0 |
2021-02-21 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 6,875 | .00 | 0 |
2021-02-21 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 6,875 | .00 | 0 |
2021-02-21 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 4,800 | .00 | 0 |
2021-02-21 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 32,400 | .00 | 0 |
2021-02-20 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 4,589 | .00 | 0 |
2021-02-20 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 3,824 | .00 | 0 |
2021-02-20 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 10,095 | .00 | 0 |
2021-02-20 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 7,036 | .00 | 0 |
2021-02-20 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 4,589 | .00 | 0 |
2021-02-20 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 11,178 | .00 | 0 |
2021-02-17 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 2,250 | .00 | 0 |
2021-02-17 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 2,500 | .00 | 0 |
2021-02-17 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 2,500 | .00 | 0 |
2021-02-17 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 3,000 | .00 | 0 |
2021-02-17 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 8,750 | .00 | 0 |
2021-02-16 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 2,375 | .00 | 0 |
2021-02-16 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 3,375 | .00 | 0 |
2021-02-16 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 3,375 | .00 | 0 |
2021-02-16 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 2,375 | .00 | 0 |
2021-02-16 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 3,375 | .00 | 0 |
2021-02-16 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 18,125 | .00 | 0 |
2021-01-13 | Dixon Wendy L (Director) | Option Ex | 35,000 | 12.62 | 441,700 |
2020-10-01 | Mitchell Paul J (Director) | Sale | 20,000 | 16.61 | 332,260 |
2020-10-01 | Mitchell Paul J (Director) | Option Ex | 20,000 | 14.92 | 298,400 |
2020-09-28 | Anstice David W (Director) | Sale | 17,832 | 16.79 | 299,310 |
2020-09-28 | Anstice David W (Director) | Option Ex | 20,000 | 14.92 | 298,400 |
2020-07-14 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 5,523 | 18.11 | 99,993 |
2020-06-07 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 1,250 | .00 | 0 |
2020-06-05 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 3,500 | .00 | 0 |
2020-05-14 | Frates James M (SVP, Alks Inc; CFO ALKS) | Option Ex | 21,983 | 11.74 | 258,080 |
2020-05-14 | Pops Richard F (Director and CEO, Alkermes plc) | Sale | 75,000 | 15.00 | 1,125,225 |
2020-05-14 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 75,000 | 11.74 | 880,500 |
2020-05-13 | Brown Iain Michael (SVP Finance & CAO, Alks Inc.) | Sale | 6,250 | 15.39 | 96,193 |
2020-05-13 | Brown Iain Michael (SVP Finance & CAO, Alks Inc.) | Option Ex | 6,250 | 11.74 | 73,375 |
2020-05-12 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Sale | 18,000 | 15.75 | 283,464 |
2020-05-12 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 18,000 | 11.74 | 211,320 |
2020-05-07 | Pops Richard F (Director and CEO, Alkermes plc) | Sale | 50,000 | 14.62 | 731,250 |
2020-05-07 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 50,000 | 11.74 | 587,000 |
2020-05-05 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Sale | 25,000 | 14.06 | 351,425 |
2020-05-05 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 25,000 | 11.74 | 293,500 |
2020-04-02 | Pops Richard F (Director and CEO, Alkermes plc) | Sale | 50,000 | 13.79 | 689,500 |
2020-04-02 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 50,000 | 11.74 | 587,000 |
2020-03-26 | Pops Richard F (Director and CEO, Alkermes plc) | Sale | 75,000 | 14.36 | 1,077,225 |
2020-03-26 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 75,000 | 11.74 | 880,500 |
2020-03-24 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Sale | 25,000 | 13.91 | 347,725 |
2020-03-24 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 25,000 | 11.74 | 293,500 |
2020-03-19 | Pops Richard F (Director and CEO, Alkermes plc) | Sale | 75,000 | 14.32 | 1,074,225 |
2020-03-19 | Pops Richard F (Director and CEO, Alkermes plc) | Option Ex | 75,000 | 11.74 | 880,500 |
2020-03-17 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Sale | 25,000 | 13.86 | 346,425 |
2020-03-17 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 25,000 | 11.74 | 293,500 |
2020-03-02 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 3,000 | 11.74 | 35,220 |
2020-03-01 | Gaffin David Joseph (SVP, CLO, Alkermes, Inc.) | Option Ex | 2,250 | .00 | 0 |
2020-03-01 | Brown Iain Michael (SVP Finance & CAO, Alks Inc.) | Option Ex | 2,250 | .00 | 0 |
2020-03-01 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 4,500 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
of ALKS listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Alkermes Plc. (symbol ALKS,
CIK number 1520262) see
the Securities and Exchange Commission (SEC) website.